Artemisinin Monotherapy Replacement Project: 2012-2015

Download File

Abstract

Widespread use of partial oAMT courses

  • Private sector imported ~1.2m monotherapy courses annually.
  • A single private distributor dominated the market with >70% of the market share with a highly centralized supply chain.
  • Patients typically paid ~$0.50 per treatment.